In this issue of Urologic Clinics of North America, guest editors Drs. Hanan Goldberg and Gennady Bratslavsky bring their considerable expertise to the topic of Current Management of Localized Prostate Cancer. Top experts explore recent, significant investigation and research into various aspects of the assessment and management of clinically localized disease, which has led to novel findings and ideas regarding diagnostic, imaging, pathological, genetic, and therapeutic interventions for prostate cancer.
Prostate Cancer Screening: Evolution, Challenges, and Future Directions Molecular Biomarkers for Localized Prostate Cancer: Current Progress and Future Directions Advances in Prostate Biopsy Prostate Cancer Grading: An Update The Role of Genetic Testing in Localized Prostate Cancer Imaging of Clinically Localized Prostate Cancer Should Gleason 6 Still Be Considered Cancer? A Narrative Review of its Biology and Clinical Course, with Implications for Guideline Recommendations and Practice Implementation Gleason Grade Group 1 Prostate Cancer: Arguments for and Against a Cancer Designation Active Surveillance for Prostate Cancer Focal Therapies for Localized Prostate Cancer Current Surgical Treatment of Prostate Cancer Role of Pelvic Lymph Node Dissection in the Surgical Treatment of Clinically Localized Prostate Cancer Radiation Therapy for Prostate Cancer Current and Upcoming Trials in Localized Prostate Cancer
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.